

Learn about common and serious Mestinon (Pyridostigmine) side effects, how to manage them, and when to seek medical attention. Updated for 2026.
Starting a new medication always comes with questions — and Mestinon (Pyridostigmine Bromide) is no different. Like all medications, it can cause side effects. The good news is that most are mild, manageable, and tend to improve as your body adjusts.
This guide covers the common side effects, the serious ones to watch for, and practical tips for managing them. If you're about to start Mestinon or already taking it, knowing what to expect can help you feel more confident about your treatment.
Mestinon is a cholinesterase inhibitor that works by preventing the breakdown of acetylcholine, a chemical messenger that helps your muscles contract. It's primarily used to treat myasthenia gravis, a condition that causes muscle weakness. It's also prescribed off-label for POTS, orthostatic hypotension, and other autonomic conditions.
Because Mestinon increases acetylcholine levels throughout your body — not just at the muscles you want to target — it can affect your digestive system, salivary glands, sweat glands, and other organs. That's where most side effects come from.
These side effects are the most frequently reported. They're usually mild to moderate and often improve within a few days to weeks of starting treatment:
Most of these side effects are dose-related — meaning they tend to get worse at higher doses and better at lower doses. Your doctor can adjust your dose to find the right balance between symptom relief and side effects.
Serious side effects from Mestinon are uncommon but require immediate medical attention:
When to call your doctor or 911:
Mestinon is classified as pregnancy risk equivalent to Category C. It should be used during pregnancy only if clearly needed. Pyridostigmine can cross the placenta, and there have been reports of temporary muscle weakness in newborns of mothers taking the medication. If you're pregnant or planning to become pregnant, discuss the risks and benefits with your neurologist.
Pyridostigmine is excreted in breast milk. While it's generally considered compatible with breastfeeding at typical doses, you should discuss this with your doctor and monitor your baby for any signs of GI upset or unusual fussiness.
Elderly patients may be more sensitive to the cholinergic effects of Mestinon, including digestive side effects and changes in heart rate. Lower starting doses and slower dose increases are often recommended.
Pyridostigmine is partially eliminated by the kidneys. If you have kidney disease, your doctor may need to adjust your dose to prevent side effects from drug accumulation.
Here are practical strategies that many Mestinon patients find helpful:
If side effects are interfering with your quality of life, don't adjust your dose on your own. Talk to your doctor — there are usually ways to modify the regimen without sacrificing symptom control. You can also learn more about how Mestinon works to better understand why these side effects happen.
Mestinon is a well-established medication that has helped millions of people with myasthenia gravis and other conditions. While side effects are common — especially GI symptoms — most patients find they're manageable with simple strategies like taking the medication with food and starting at a low dose.
The key is knowing the difference between expected side effects and warning signs that need medical attention. If you experience severe weakness, breathing difficulties, or a very slow heart rate, seek help immediately.
If you're having trouble finding Mestinon at your pharmacy, Medfinder can help you check stock near you so you don't miss a dose.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.